A man is taking part in a £6.4m clinical trial after losing his dad and uncle to cancer within days of each other. Dean Burton, from Coventry, has been on lifelong medication for heartburn - which he ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's ...

SBRT may ease toxicity, but the lower doses could come at the expense of cancer control, new data indicate. Experts suggest a ...

The Alliance for Clinical Trials in Oncology has launched the ASPIRE trial—a large-scale, Phase III clinical study investigating whether adding chemotherapy to current standard treatments can extend ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...

AdvanCell to present promising clinical trial results of ADVC001, a novel Lead-212-based PSMA-targeted alpha therapy for prostate cancer, at ESMO ...

The Alliance for Clinical Trials in Oncology has launched the ASPIRE trial-a large-scale, Phase III clinical study investigating whether adding chemotherapy to current standard treatments can extend ...

Sean “Diddy” Combs’ request for a new trial or an acquittal in his federal case has been denied, just ahead of his sentencing on Friday. Judge Arun Subramanian declared in a filing on Tuesday evening ...